Structural Heart Closure Devices | Market Insights | Global | 2023
Despite the initial negative impact of the COVID-19 pandemic, the global structural heart closure device market will grow rapidly through 2031. The growth was supported by expanding patient population, strong clinical data, the availability of reimbursement, a growing body of trained physicians, the uptake of premium-priced technologies, and growing adoption of next-generation devices, especially in the PFO and LAA closure device spaces. However, the growth will be limited to some extent by cost-containment measures such as MACRA and the 2-Midnight Rule in the US, intense pricing pressures due to economic constraints in Europe, the new MDR challenges and the biennial reimbursement cuts by the Japanese MHLW.
This Medtech 360 Report provides comprehensive data and analysis on the state of the global structural heart closure device market from 2019 through 2031.
